+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Protein Therapeutics Market Research Report by Protein Function (Enzymatic and Regulatory, Protein Diagnostics, and Vaccines), Product Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968900
  • Report
  • April 2022
  • Region: Global
  • 217 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Ambrx
  • Atomwise
  • Editas Medicine
  • Good Therapeutics
  • Leiden University Medical
  • Omeros
The Global Protein Therapeutics Market size was estimated at USD 67.83 billion in 2021, USD 73.00 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.80% to reach USD 106.45 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Protein Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Protein Function, the market was studied across Enzymatic and Regulatory, Protein Diagnostics, and Vaccines.
  • Based on Product Type, the market was studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Protein Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Therapeutics Market, including Ambrx, Aravive, AstraZeneca PLC, Atomwise, Autolus, DesigneRx Pharmaceuticals, Editas Medicine, F. Hoffmann-La Roche AG, Genentech, Good Therapeutics, Institut Pasteur, LabGenius, Leiden University Medical, LGC Group, Morphic Therapeutic, Omeros, Pfizer, ProteinQure, Sanofi S.A., SilkTech Biopharmaceuticals, Translate Bio, Trinity College Dublin, and Venturis Therapeutics.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Protein Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?
6. What is the market share of the leading vendors in the Global Protein Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Protein Therapeutics Market?
Frequently Asked Questions about the Global Protein Therapeutics Market

What is the estimated value of the Global Protein Therapeutics Market?

The Global Protein Therapeutics Market was estimated to be valued at $67.8 Billion in 2021.

What is the growth rate of the Global Protein Therapeutics Market?

The growth rate of the Global Protein Therapeutics Market is 7.8%, with an estimated value of $106.5 Billion by 2027.

What is the forecasted size of the Global Protein Therapeutics Market?

The Global Protein Therapeutics Market is estimated to be worth $106.5 Billion by 2027.

Who are the key companies in the Global Protein Therapeutics Market?

Key companies in the Global Protein Therapeutics Market include Ambrx, Aravive, AstraZeneca PLC, Atomwise, Autolus, DesigneRx Pharmaceuticals, Editas Medicine, F. Hoffmann and Genentech.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ambrx
  • Atomwise
  • Editas Medicine
  • Good Therapeutics
  • Leiden University Medical
  • Omeros

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing healthcare expenditure in the emerging markets
5.1.1.2. Government initiatives to improve the healthcare services
5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
5.1.2. Restraints
5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
5.1.3. Opportunities
5.1.3.1. Potential for bispecific monoclonal antibodies
5.1.3.2. Unmet medical needs in developing countries
5.1.4. Challenges
5.1.4.1. High cost of production and treatment
5.1.4.2. Competition from biosimilars
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Protein Therapeutics Market, by Protein Function
6.1. Introduction
6.2. Enzymatic and Regulatory
6.3. Protein Diagnostics
6.4. Vaccines
7. Protein Therapeutics Market, by Product Type
7.1. Introduction
7.2. Blood Clotting Factor
7.3. Erythropoietin
7.4. Follicle Stimulating Hormone
7.5. G-CSF
7.6. Insulin
7.7. Interferons
7.8. Monoclonal Antibodies
8. Americas Protein Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Protein Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Protein Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Ambrx
12.2. Aravive
12.3. AstraZeneca PLC
12.4. Atomwise
12.5. Autolus
12.6. DesigneRx Pharmaceuticals
12.7. Editas Medicine
12.8. F. Hoffmann-La Roche AG
12.9. Genentech
12.10. Good Therapeutics
12.11. Institut Pasteur
12.12. LabGenius
12.13. Leiden University Medical
12.14. LGC Group
12.15. Morphic Therapeutic
12.16. Omeros
12.17. Pfizer
12.18. ProteinQure
12.19. Sanofi S.A.
12.20. SilkTech Biopharmaceuticals
12.21. Translate Bio
12.22. Trinity College Dublin
12.23. Venturis Therapeutics
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PROTEIN THERAPEUTICS MARKET: DYNAMICS
FIGURE 2. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2027
FIGURE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 30. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 31. CANADA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 32. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. CHINA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. ITALY PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. QATAR PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. GLOBAL PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL PROTEIN THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 60. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROTEIN THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PROTEIN THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 56. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 57. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 58. CANADA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 59. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 60. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 61. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 62. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 63. CHINA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 64. INDIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 65. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. ITALY PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. QATAR PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. GLOBAL PROTEIN THERAPEUTICS MARKET: SCORES
TABLE 86. GLOBAL PROTEIN THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 87. GLOBAL PROTEIN THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 88. GLOBAL PROTEIN THERAPEUTICS MARKET: RANKING
TABLE 89. GLOBAL PROTEIN THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 90. GLOBAL PROTEIN THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 91. GLOBAL PROTEIN THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 92. GLOBAL PROTEIN THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 93. GLOBAL PROTEIN THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 94. GLOBAL PROTEIN THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 95. GLOBAL PROTEIN THERAPEUTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Ambrx
  • Aravive
  • AstraZeneca PLC
  • Atomwise
  • Autolus
  • DesigneRx Pharmaceuticals
  • Editas Medicine
  • F. Hoffmann-La Roche AG
  • Genentech
  • Good Therapeutics
  • Institut Pasteur
  • LabGenius
  • Leiden University Medical
  • LGC Group
  • Morphic Therapeutic
  • Omeros
  • Pfizer
  • ProteinQure
  • Sanofi S.A.
  • SilkTech Biopharmaceuticals
  • Translate Bio
  • Trinity College Dublin
  • Venturis Therapeutics
Note: Product cover images may vary from those shown

Loading
LOADING...